Pharmacyclics

Pharmaceuticals & Biotech

Pharmacyclics Careers, Pay and Expert Network

lightbulbWhat are the highest paying jobs at Pharmacyclics?

Pharmacyclics LLC is an American biopharmaceutical company based in Sunnyvale, California. Its primary focus is upon the development of "novel therapies for the treatment of cancer and immune-mediated diseases." In March 2015, Chicago-based biopharmaceutical firm AbbVie announced it would acquire oncology firm Pharmacyclics, as well as its lead anti-cancer compound ibrutinib (Imbruvica) for $21 billion. As part of the deal AbbVie will pay $261.25 per share in a mixture of both cash and AbbVie equity. The merger is expected to close in mid-2015. Duggan will receive over $3.55 billion from the sale of Pharmacyclics to AbbVie in "one of the biggest paydays ever from the buyout of a publicly held company."

Snapshot

Founded1991
Annual Report
Total Experts:
2
% Masters:
45%

Top Experts at Pharmacyclics